Expertise in
7
conditions

Dr. Paul G. Matherne

Family Medicine
Elenbaas & Doty PLLC
1924 E Pass Rd, 
Gulfport, MS 
Accepting New Patients
Offers Telehealth
Expertise in
7
conditions
Elenbaas & Doty PLLC
1924 E Pass Rd, 
Gulfport, MS 

Overview

Paul Matherne is a primary care provider, practicing in Family Medicine in Gulfport, Mississippi.

Dr. Matherne is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Glucocorticoid-Remediable Aldosteronism, Hypertension, Familial Hypertension, Maturity Onset Diabetes of the Young, and Gastrostomy.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 6 clinical trials. Dr. Matherne is currently accepting new patients.

Specialties

Family Medicine

Licenses

Family Medicine in MS

Hospital Affiliations

Singing River Health System
Memorial Hospital Biloxi
Singing River Gulfport
Memorial Hospital At Gulfport

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Magnolia Health
  • HMO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MetLife
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Elenbaas & Doty PLLC
1924 E Pass Rd, Gulfport, MS 39507

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase III, Randomized, Double-blind, Placebo-controlled Multi-country Study to Demonstrate Efficacy of a Single Dose of Unadjuvanted RSV Maternal Vaccine, Administered IM to Pregnant Women 18 to 49 Years of Age, for Prevention of RSV Associated LRTIs in Their Infants up to 6 Months of Age
A Phase III, Randomized, Double-blind, Placebo-controlled Multi-country Study to Demonstrate Efficacy of a Single Dose of Unadjuvanted RSV Maternal Vaccine, Administered IM to Pregnant Women 18 to 49 Years of Age, for Prevention of RSV Associated LRTIs in Their Infants up to 6 Months of Age
Enrollment Status: Terminated
Publish Date: February 20, 2025
Intervention Type: Biological, Drug
Study Drug: RSV Maternal vaccine
Study Phase: Phase 3
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine
Enrollment Status: Completed
Publish Date: June 28, 2024
Intervention Type: Drug
Study Drugs: Galcanezumab, Rimegepant
Study Phase: Phase 4
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
Enrollment Status: Completed
Publish Date: December 21, 2023
Intervention Type: Biological, Other
Study Drug: SARS-CoV-2 rS/Matrix-M1 Adjuvant
Study Phase: Phase 3
A Phase II, Randomised, Observer-blind, Placebo Controlled Multi-country Study to Assess the Safety, Reactogenicity and Immunogenicity of a Single Intramuscular Dose of GSK Biologicals' Investigational RSV Maternal Unadjuvanted Vaccine (GSK3888550A), in Healthy Pregnant Women Aged 18 to 40 Years and Infants Born to Vaccinated Mothers
A Phase II, Randomised, Observer-blind, Placebo Controlled Multi-country Study to Assess the Safety, Reactogenicity and Immunogenicity of a Single Intramuscular Dose of GSK Biologicals' Investigational RSV Maternal Unadjuvanted Vaccine (GSK3888550A), in Healthy Pregnant Women Aged 18 to 40 Years and Infants Born to Vaccinated Mothers
Enrollment Status: Completed
Publish Date: December 13, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 2
Phase 2B Double-blind Placebo-controlled Efficacy Trial of EVO100 (Previously Known as Amphora ® Gel) for the Prevention of Acquisition of Urogenital Chlamydia Trachomatis Infection
Phase 2B Double-blind Placebo-controlled Efficacy Trial of EVO100 (Previously Known as Amphora ® Gel) for the Prevention of Acquisition of Urogenital Chlamydia Trachomatis Infection
Enrollment Status: Completed
Publish Date: August 12, 2020
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Double Blind, Multi-center, Randomized, Placebo-Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Ropivacaine 0.2% Pre-Filled Dispenser for the Treatment of Postsurgical Pain in Patients Undergoing Cesarean Delivery
A Double Blind, Multi-center, Randomized, Placebo-Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Ropivacaine 0.2% Pre-Filled Dispenser for the Treatment of Postsurgical Pain in Patients Undergoing Cesarean Delivery
Enrollment Status: Completed
Publish Date: August 14, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

2 Total Publications

Safety and immunogenicity of a single-dose omicron-containing COVID-19 vaccination in adolescents: an open-label, single-arm, phase 2/3 trial.
Safety and immunogenicity of a single-dose omicron-containing COVID-19 vaccination in adolescents: an open-label, single-arm, phase 2/3 trial.
Journal: The Lancet. Infectious diseases
Published: March 22, 2024
Similar Doctors
Expertise in
23
conditions
Dr. Steven M. Schepens
Family Medicine
Expertise in
23
conditions
Dr. Steven M. Schepens
Family Medicine

Medical Foundation Of South MS

394 Courthouse Rd Ste A, 
Gulfport, MS 
 (1.2 miles away)
228-896-4417
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Steven Schepens is a primary care provider, practicing in Family Medicine in Gulfport, Mississippi. Dr. Schepens is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Photosensitive Epilepsy, Landau-Kleffner Syndrome, Continuous Spike-Wave During Slow Sleep Syndrome, and Emphysema. Dr. Schepens is currently accepting new patients.

Expertise in
16
conditions
Dr. Paul M. Pavlov
Family Medicine
Expertise in
16
conditions
Dr. Paul M. Pavlov
Family Medicine
Before you request

Gulf Medical LLC

15012 Lemoyne Blvd, 
Biloxi, MS 
 (9.5 miles away)
228-392-5050
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Paul Pavlov is a primary care provider, practicing in Family Medicine in Biloxi, Mississippi. Dr. Pavlov is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Hypertension, Endoscopy, and Pacemaker Implantation. Dr. Pavlov is currently accepting new patients.

Expertise in
25
conditions
Dr. Gene D. Cathey
Family Medicine
Expertise in
25
conditions
Dr. Gene D. Cathey
Family Medicine

Memorial Physician Clinic At Cedar Lake

1756 Popps Ferry Rd, 
Biloxi, MS 
 (5.3 miles away)
228-865-3200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Gene Cathey is a primary care provider, practicing in Family Medicine in Biloxi, Mississippi. Dr. Cathey is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Maturity Onset Diabetes of the Young, Hypothyroidism, Type 2 Diabetes (T2D), and Familial Hypertension. Dr. Cathey is currently accepting new patients.

Frequently Asked Questions about Dr. Paul G. Matherne

How do I make an appointment with Dr. Paul G. Matherne?

You can book an appointment with Dr. Paul G. Matherne by calling their office at 228-388-4862. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Paul G. Matherne a top-rated expert for Glucocorticoid-Remediable Aldosteronism?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Paul G. Matherne is classified as an Advanced expert for Glucocorticoid-Remediable Aldosteronism, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Paul G. Matherne specialize in?

While Dr. Paul G. Matherne is a Family Medicine, they have specific expertise in Glucocorticoid-Remediable Aldosteronism, Hypertension, and Familial Hypertension. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Family Medicine.

Does Dr. Paul G. Matherne participate in research or clinical trials?

Yes. Dr. Paul G. Matherne has published 2 articles and abstracts on conditions like Glucocorticoid-Remediable Aldosteronism. You can view a list of Dr. Paul G. Matherne's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Paul G. Matherne accept my insurance?

Dr. Paul G. Matherne accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 228-388-4862 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Matherne's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 72 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile